文献速递呼吸衰竭与机械通气重症综合管理与镇静镇痛

体外循环心脏术后血清降钙素原对中重度急性呼吸窘迫综合征的预测价值

[Predictive value of postoperative serum procalcitonin concentration for moderate to severe acute respiratory distress syndrome in patients undergoing cardiopulmonary bypass surgery].
PubMed 文献 · Zhonghua Wei Zhong Bing Ji Jiu Yi Xue · 2023-01-01
一句话结论体外循环心脏术后第1天血清PCT≥7.165 μg/L时,预测中重度ARDS的敏感度75.7%、特异度84.5%,AUC 0.827。

该研究回顾性分析2017年1月至2019年12月福建省立医院体外循环心脏手术成人患者108例,按柏林定义分为中重度ARDS组37例与无或轻度ARDS组71例。中重度ARDS组术后第1天PCT和NT-proBNP显著高于无或轻度ARDS组,PCT预测中重度ARDS的AUC为0.827,切值7.165 μg/L时敏感度75.7%、特异度84.5%。多因素Logistic回归显示年龄和PCT升高是中重度ARDS的独立危险因素。提示术后PCT可能有助于早期识别中重度ARDS高风险患者。

要点

  • 体外循环心脏术后第1天PCT预测中重度ARDS的AUC为0.827(95%CI 0.739-0.915,P<0.05)。
  • PCT切值7.165 μg/L时,预测中重度ARDS的敏感度75.7%、特异度84.5%。
  • 中重度ARDS组术后第1天PCT中位数16.33 μg/L,高于无或轻度ARDS组的2.21 μg/L(P<0.05)。
  • 年龄(OR=1.105,95%CI 1.037-1.177,P=0.002)和PCT升高(OR=48.286,95%CI 10.282-226.753,P<0.001)是中重度ARDS的独立危险因素。
  • 中重度ARDS组病死率8.1%,无或轻度ARDS组为0(P<0.05)。

适用人群与场景

  • 2017年1月至2019年12月在福建省立医院行体外循环心脏手术、术后入住ICU超过1天且术后第1天有PCT值的成人患者。

诊断标准与关键阈值

  • ARDS诊断由两名临床医生依据柏林定义独立判断,诊断一致才成立。
  • 按柏林定义分为无ARDS、轻度ARDS、中度ARDS和重度ARDS。

研究设计与关键结果

  • 回顾性分析108例患者,其中轻度ARDS 37例(34.3%)、中度ARDS 35例(32.4%)、重度ARDS 2例(1.9%)、无ARDS 34例。
  • 与无或轻度ARDS组相比,中重度ARDS组年龄更大(58.5±11.1岁 vs. 52.8±14.8岁,P<0.05),合并高血压比例更高[45.9%(17/37) vs. 25.4%(18/71),P<0.05],手术时间更长(363.2±120.6分钟 vs. 313.5±97.6分钟,P<0.05),病死率更高(8.1% vs. 0,P<0.05)。
  • 两组VIS评分、急性肾衰竭发生率、体外循环时间、主动脉阻断时间、术中出血量、输血量和液体平衡无差异。
  • 中重度ARDS组术后第1天PCT[16.33(6.96,32.56)μg/L vs. 2.21(0.80,5.76)μg/L]和NT-proBNP[2 405.0(1 543.0,6 456.5)ng/L vs. 1 680.0(1 388.0,4 667.0)ng/L]均显著高于无或轻度ARDS组(均P<0.05)。
  • PCT预测中重度ARDS的ROC曲线AUC为0.827(95%CI 0.739-0.915,P<0.05);切值7.165 μg/L时敏感度75.7%、特异度84.5%。
  • 多因素Logistic回归显示年龄(OR=1.105,95%CI 1.037-1.177,P=0.002)和PCT升高(OR=48.286,95%CI 10.282-226.753,P<0.001)是中重度ARDS的独立危险因素。

证据类型、等级与局限

  • 证据类型:回顾性分析。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 对于体外循环心脏术后成人患者,术后第1天血清PCT水平可能有助于预测中重度ARDS的发生,切值为7.165 μg/L(作者认为)。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVE: To explore the changes of serum procalcitonin (PCT) level in patients with moderate and severe acute respiratory distress syndrome (ARDS) after cardiac surgery under cardiopulmonary bypass (CPB), and try to find out the best cut-off of PCT to predict the progression to moderate and severe ARDS.

METHODS: Medical records of patients undergoing cardiac surgery with CPB in Fujian Provincial Hospital from January 2017 to December 2019 were retrospectively analyzed. Adult patients who were admitted in intensive care unit (ICU) for more than 1 day and had PCT values on the first postoperative day were enrolled. Clinical data such as patient demographics, past history, diagnosis, and New York Heart Association (HYHA) classification, and the operation mode, procedure duration, CPB duration, aortic clamp duration, intraoperative fluid balance, calculation of 24 hours postoperative fluid balance and vasoactive-inotropic score (VIS); 24 hours postoperative C-reactive protein (CRP), N-terminal B-type natriuretic peptide precursor (NT-proBNP) and PCT levels were collected. Two clinicians independently made the diagnosis of ARDS according to the Berlin definition, and the diagnosis was established only in patients with a consistent diagnosis. The differences in each parameter were compared between patients with moderate to severe ARDS and those without or with mild ARDS. Analysis of the ability of PCT to predict moderate to severe ARDS was evaluated by receiver operator characteristic curve (ROC curve). Multivariate Logistic regression was conducted to determine the risk factors of the development of moderate to severe ARDS.

RESULTS: 108 patients were finally enrolled, including 37 patients with mild ARDS (34.3%), 35 patients with moderate ARDS (32.4%), 2 patients with severe ARDS (1.9%), and 34 patients without ARDS. Compared with patients with no or mild ARDS, patients with moderate to severe ARDS were older (years old: 58.5±11.1 vs. 52.8±14.8, P < 0.05), with a higher proportion of combined hypertension [45.9% (17/37) vs. 25.4% (18/71), P < 0.05], longer operative time (minutes: 363.2±120.6 vs. 313.5±97.6, P < 0.05), and higher mortality (8.1% vs. 0, P < 0.05), but there were no differences in the VIS score, incidence of acute renal failure (ARF), CPB duration, aortic clamp duration, and intraoperative bleeding, transfusion volume, and fluid balance between the two groups. Serum PCT and NT-proBNP levels in patients with moderate to severe ARDS at postoperative day 1 were significantly higher than those in patients with no or mild ARDS [PCT (μg/L): 16.33 (6.96, 32.56) vs. 2.21 (0.80, 5.76), NT-proBNP (ng/L): 2 405.0 (1 543.0, 6 456.5) vs. 1 680.0 (1 388.0, 4 667.0), both P < 0.05]. ROC curve analysis showed that the area under the curve (AUC) for PCT to predict the occurrence of moderate to severe ARDS was 0.827 [95% confidence interval (95%CI) was 0.739-0.915, P < 0.05]. When PCT cut-off value was 7.165 μg/L, the sensitivity was 75.7% and the specificity was 84.5%, for differentiating patients who developed moderate to severe ARDS from who did not. Multivariate Logistic regression showed that age and the elevated PCT concentration were independent risk factors for the development of moderate to severe ARDS [age: odds ratio (OR) = 1.105, 95%CI was 1.037-1.177, P = 0.002; PCT: OR = 48.286, 95%CI was 10.282-226.753, P < 0.001].

CONCLUSIONS: Patients with moderate to severe ARDS undergoing CPB cardiac surgery have a higher serum concentration of PCT than patients with no or mild ARDS. Serum PCT level may be a promising biomarker to predict the development of moderate to severe ARDS, the cut-off value is 7.165 μg/L.

来源:Zhonghua Wei Zhong Bing Ji Jiu Yi Xue,查看原文。版权归原作者所有。

参考来源

  1. Li M, Chen H, Yu R, et al. [Predictive value of postoperative serum procalcitonin concentration for moderate to severe acute respiratory distress syndrome in patients undergoing cardiopulmonary bypass surgery]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2023. PMID: 37308228. doi:10.3760/cma.j.cn121430-20211122-01760

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。